Clinical trials
Terminated Phase 1/2 Carcinoma, Ovarian Epithelial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 3 |
| Amgen | 1 |
| Elucida Oncology | 1 |
| Fox Chase Cancer Center | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| M.D. Anderson Cancer Center | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| Medical University Innsbruck | 1 |
| National Cancer Centre, Singapore | 1 |
| Opna Bio LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 16 |
| Ovarian Neoplasms | 9 |
| Fallopian Tube Neoplasms | 7 |
| Breast Neoplasms | 2 |
| Recurrence | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Adenocarcinoma of Lung | 1 |
| Anemia | 1 |
| Anemia, Iron-Deficiency | 1 |
| Breast Neoplasms, Male | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.